KLab has a dedicated oncology
facility for manufacturing various APIs. KLab also
has a separate sterile powder manufacturing
facility. The API dossier's available are equivalent
to CTD (Europe), DMF (US) standards subject to site
approvals. KLab has got WHO GMP/ cGMP / ISO 14001 /
ISO 9001 and GLP certifications.

ANTI NEOPLASTIC

CAS NO

Anastrazole IP / USP

120511-73-1

Bicalutamide USP

90357-06-5

Bortezomib IHS

179324-69-7

Capacitabine IP / USP

154361-50-9

Carboplatin BP /
USP

41575-94-4

Cisplatin IP / BP/
USP

15663-27-1

Cyclophosphamide
(Sterile / NON STERILE)
IP / BP / USP / EP

6055-19-2

Erlotinib
hydrochloride IHS

183319-69-9

Gefitinib IP/IHS

184475-35-2

Gemcitabine
Hydrochloride BP / USP

95058-81-4

Hydroxyurea BP / USP

127-07-1

Imatinib Mesylate
IP / IHS

220127-57-1

Letrozole BP / USP

112809-51-5

Methotrexate I P /
USP

6745-93-3

Tamoxifen Citrate IP / BP / USP

54965-24-1

Zolendronic acid IP / IHS

118072-93-8

* IHS : In House Standard

Present

Introduced Patented Products based on
NDDS(Marketed in India and out-Licensed for the
Developing Countries)

Future

Patents driven
by NDDS, Nano and Dendrimers(To be marketed in India and to be out Licensed to
the developed countries)